Dennis R. Hill, MD to Present “Active Surveillance vs. High Dose Rate Brachytherapy” to the Summit Medical Staff

Dennis R. Hill, MD Slated to Present “Active Surveillance vs. High Dose Rate Brachytherapy” at the Continuing Medical Education Conference for the Summit Medical Staff of the Alta Bates Summit Medical Center Thursday Oct 3

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Oakland, CA (PRWEB) October 02, 2013

Dennis R. Hill, MD confirmed today that he will present “Active Surveillance vs. High Dose Rate Brachytherapy” at the Continuing Medical Education Conference for the Summit Medical Staff of the Alta Bates Summit Medical Center Thursday Oct 3. The conference is scheduled from 12:15pm to 1:15pm at the Merritt Pavilion of the Summit campus in Oakland. It will be in the Fir Conference Room. His intention is to raise awareness of active surveillance in selected patients with prostate cancer and increase the awareness of High Dose Rate brachytherapy as a safe, efficient method of treatment for prostate cancer with few side effects. Dr. Hill comments, “There is a changing paradigm in prostate cancer on several fronts, including screening, diagnosis and treatment. It can be confusing. Hopefully, I can bring the latest information out, but also some common sense on how to approach this important cancer.” Following the formal presentation there will be a question and answer session with the attending physicians. The event is sponsored by the Jordan Research and Education Institute of the Alta Bates Summit Medical Center. Physicians can obtain one Continuing Medical Education credit by attending the conference.

About Dennis R. Hill MD

Dr. Hill has been doing High Dose Rate Brachytherapy for prostate cancer treatment exclusively since 2004 and has published scholarly articles on the subject. His office is located at: Dennis R. Hill MD, 3012 Summit Street Suite 2675, Oakland, CA 94609; 510-869-8875; drh(at)dennisrhillmd(dot)com and his website is hdrprostatebrachytherapy.com, which includes a quiz to determine if a patient is a candidate for HDR Prostate Brachytherapy.


Contact